131 related articles for article (PubMed ID: 10182194)
1. The economics of TRACE. A cost-effectiveness analysis of trandolapril in postinfarction patients with left ventricular dysfunction.
LePen C; Lilliu H; Keller T; Fiessinger S
Pharmacoeconomics; 1998 Jul; 14(1):49-58. PubMed ID: 10182194
[TBL] [Abstract][Full Text] [Related]
2. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
Torp-Pedersen C; Køber L
Lancet; 1999 Jul; 354(9172):9-12. PubMed ID: 10406358
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event.
Gustafsson F; Torp-Pedersen C; Køber L; Hildebrandt P
J Hypertens; 1997 Jul; 15(7):793-8. PubMed ID: 9222948
[TBL] [Abstract][Full Text] [Related]
5. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
Aliot E
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315
[TBL] [Abstract][Full Text] [Related]
6. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.
Gustafsson I; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P
J Am Coll Cardiol; 1999 Jul; 34(1):83-9. PubMed ID: 10399995
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Torp-Pedersen C; Køber L; Carlsen J
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
[TBL] [Abstract][Full Text] [Related]
8. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
9. Trandolapril in left ventricular dysfunction after myocardial infarction: focus on the TRACE study.
Coca A; Rabasseda X
Drugs Today (Barc); 2003 Jan; 39(1):5-18. PubMed ID: 12669106
[TBL] [Abstract][Full Text] [Related]
10. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
[TBL] [Abstract][Full Text] [Related]
12. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.
Pedersen OD; Bagger H; Kober L; Torp-Pedersen C
Circulation; 1999 Jul; 100(4):376-80. PubMed ID: 10421597
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function.
Abdulla J; Burchardt H; Z Abildstrøm S; Køber L; Torp-Pedersen C;
Eur Heart J; 2003 Dec; 24(23):2116-22. PubMed ID: 14643272
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.
Weintraub WS; Zhang Z; Mahoney EM; Kolm P; Spertus JA; Caro J; Ishak J; Goldberg R; Tooley J; Willke R; Pitt B
Circulation; 2005 Mar; 111(9):1106-13. PubMed ID: 15723981
[TBL] [Abstract][Full Text] [Related]
15. [Cost effectiveness of captopril after myocardial infarct; comment].
Szucs T; Berger K; Schulte-Hillen J; Kleber FX
Med Klin (Munich); 1996 Feb; 91(2):112-8. PubMed ID: 8850108
[TBL] [Abstract][Full Text] [Related]
16. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.
Peters DC; Noble S; Plosker GL
Drugs; 1998 Nov; 56(5):871-93. PubMed ID: 9829159
[TBL] [Abstract][Full Text] [Related]
17. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
Gustafsson F; Køber L; Torp-Pedersen C; Per Hildebrandt
J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
[TBL] [Abstract][Full Text] [Related]
19. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
Buksa M
Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study.
Køber L; Torp-Pedersen C
Am J Cardiol; 1995 Jul; 76(1):1-5. PubMed ID: 7793393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
